Motiva SilkSurface is 4-micron texturing. Biocell — the implant that was recalled and most linked to BIA-ALCL — was 90 microns. Smooth implants are 0 to 2 microns. Motiva is essentially in the smooth category, not the macro-textured one. The cancer narrative being spread doesn't match the science.
A lot of misinformation about Motiva implants is circulating on social media right now, much of it conflating Motiva's SilkSurface texturing with the older macro-textured implants that have been associated with BIA-ALCL.
These are very different surfaces — and the difference matters a lot for understanding the actual cancer risk. Let me walk through what we know and why I'm not personally concerned about BIA-ALCL with Motiva implants.
BIA-ALCL stands for breast implant-associated anaplastic large cell lymphoma. It's a rare cancer that's been associated with textured implants — particularly a specific kind of texturing.
All of the cases of BIA-ALCL we've seen in the United States have come from patients with textured implants. The implants most clearly linked:
What these all have in common: a macro-texturing approach, with surface features on the order of 90 microns.
For deeper background on the cancer risk, I wrote about BIA-ALCL, BIA-SCC, and Motiva implants in more depth here — but I want to focus today specifically on the texturing distinction.
Motiva implants have what's called a SilkSurface (sometimes also marketed as Motiva's nano-texturing). It looks different than smooth implants under magnification — but it's also dramatically different than the macro-textured implants that have been associated with ALCL.
Let me put the numbers on it:
| Surface Type | Texturing Depth |
|---|---|
| Smooth implant | 0–2 microns |
| Motiva SilkSurface | ~4 microns |
| Biocell macro-texturing (recalled) | ~90 microns |
The Motiva surface is vastly closer to a smooth implant (4 microns vs. 0–2) than it is to a macro-textured implant (4 microns vs. 90). It's in essentially a different category of surface.
So when people say "Motiva is textured, therefore it's probably cancer-causing" — that's a misunderstanding of what kind of texturing actually drove the BIA-ALCL signal in the historical data.
Here's another piece of the puzzle that's been studied directly.
The mechanism we believe drives ALCL in macro-textured implants is chronic low-grade inflammation at the implant-capsule interface, driven by the rough surface's interaction with the surrounding tissue.
Motiva's SilkSurface has been studied specifically for inflammation, and the result is striking:
It induces very low inflammation in the body — among the lowest of any breast implant surface studied.
That low inflammatory profile is part of why we believe Motiva is not driving the same biological process that macro-textured implants did.
Based on the current data:
I and most plastic surgeons doing modern reconstructive and cosmetic implant work are comfortable using Motiva implants and do not believe they cause BIA-ALCL.
That said: we're always watching everything carefully. Smooth implants are watched too. You don't know what you don't know — and our understanding of these things evolves over time. But based on what we currently understand:
There is no evidence that the Motiva implant induces BIA-ALCL. Claiming otherwise is misinformation.
Two reasons, I think — one innocent, one less so.
Plenty of patients and creators see the word "textured" in the same paragraph as the word "cancer" and reasonably get worried. They don't necessarily have the technical context to distinguish 4-micron nano-texturing from 90-micron macro-texturing. So they spread their concern in good faith, even though the underlying conflation doesn't hold up to scrutiny.
This is the part that I think is worth being honest about.
Motiva implants can only be used by board-certified plastic surgeons in the United States. The company takes patient safety seriously enough that they've restricted which clinicians can purchase and use the product.
What this means in practice:
Guess who is making a lot of the videos suggesting that Motiva implants are "dangerous" or that they're "concerned about the safety"?
If you trace the source of much of the anti-Motiva content circulating online, you will find clinicians who:
That's a conflict of interest worth knowing about. The skepticism is being driven in part by people whose business model is being challenged by the implant's existence and popularity.
This connects to a broader pattern I've written about regarding chop-shop chains and creator ethics in medicine. Always worth asking: who is making the claim, and what's the business angle behind it?
If you're considering an augmentation or reconstruction and you're wading through implant choices:
For the broader question of how surgeons actually choose implants and whether financial relationships influence those choices, the bottom line is: most surgeons stick with 1–2 brands based on familiarity, consignment, and volume pricing, not because they're paid to push them.
Motiva's SilkSurface texturing is not the same as the macro-textured implants associated with BIA-ALCL. The surface profile is dramatically different (4 microns vs. 90 microns), the inflammatory profile is very low, and there are no cases of BIA-ALCL associated with Motiva at this time.
The anti-Motiva content circulating on social media is, in part, driven by clinicians who can't use the implant themselves because they don't meet Motiva's requirement of being board-certified plastic surgeons. That conflict of interest is rarely disclosed in those videos.
Based on the best evidence we have right now: Motiva implants are a great option for many augmentation and reconstruction patients, and the cancer concern being spread online is misinformation. That doesn't mean we're not watching carefully — we always are. But there's no current evidence to suggest you should avoid these implants on a cancer-risk basis.
Big thanks to my friend Dr. Alicia Billington for the prompt to make this video — she's been seeing the same misinformation pattern and we both think it's worth pushing back on clearly.